Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krady, J. K.
Right arrow Articles by Levison, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krady, J. K.
Right arrow Articles by Levison, S. W.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:1559-1565, 2005
© 2005 by the American Diabetes Association, Inc.

Minocycline Reduces Proinflammatory Cytokine Expression, Microglial Activation, and Caspase-3 Activation in a Rodent Model of Diabetic Retinopathy

J. Kyle Krady1, Anirban Basu1, Colleen M. Allen1, Yuping Xu2, Kathryn F. LaNoue2, Thomas W. Gardner2, and Steven W. Levison1,3

1 Department of Neural and Behavioral Sciences, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania
2 Department of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania
3 Department of Neurology and Neuroscience, University of Medicine and Dentistry in New Jersey, New Jersey Medical School, Newark, New Jersey

Diabetes leads to vascular leakage, glial dysfunction, and neuronal apoptosis within the retina. The goal of the studies reported here was to determine the role that retinal microglial cells play in diabetic retinopathy and assess whether minocycline can decrease microglial activation and alleviate retinal complications. Immunohistochemical analyses showed that retinal microglia are activated early in diabetes. Furthermore, mRNAs for interleukin-1ß and tumor necrosis factor-{alpha}, proinflammatory mediators known to be released from microglia, are also increased in the retina early in the course of diabetes. Using an in vitro bioassay, we demonstrated that cytokine-activated microglia release cytotoxins that kill retinal neurons. Furthermore, we showed that neuronal apoptosis is increased in the diabetic retina, as measured by caspase-3 activity. Minocycline represses diabetes-induced inflammatory cytokine production, reduces the release of cytotoxins from activated microglia, and significantly reduces measurable caspase-3 activity within the retina. These results indicate that inhibiting microglial activity may be an important strategy in the treatment of diabetic retinopathy and that drugs such as minocycline hold promise in delaying or preventing the loss of vision associated with this disease.


Address correspondence and reprint requests to J. Kyle Krady, PhD, Dept. of Neural and Behavioral Sciences, H109, The Pennsylvania State University College of Medicine, Hershey, PA 17033. E-mail: jkk7{at}psu.edu

Abbreviations: AMC, 7-amino-4-methyl coumarin; CNS, central nervous system; COX-2, cyclo-oxygenase-2; DAPI, 4',6-diamidino-2-phenylindole; IL, interleukin; LDH, lactate dehydrogenase; MEM, minimum essential medium; MMP, matrix metalloproteinases; NCS, newborn calf serum; ROS, reactive oxygen species; STZ, streptozotocin; TNF-{alpha}, tumor necrosis factor-{alpha}; TUNEL, transferase-mediated dUTP nick-end labeling; VEGF, vascular endothelial growth factor


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
J. V. Busik, S. Mohr, and M. B. Grant
Hyperglycemia-Induced Reactive Oxygen Species Toxicity to Endothelial Cells Is Dependent on Paracrine Mediators
Diabetes, July 1, 2008; 57(7): 1952 - 1965.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
H.-y. Zeng, W. R. Green, and M. O. M. Tso
Microglial Activation in Human Diabetic Retinopathy
Arch Ophthalmol, February 1, 2008; 126(2): 227 - 232.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. J. Walker and J. J. Steinle
Role of {beta}-Adrenergic Receptors in Inflammatory Marker Expression in Muller Cells
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5276 - 5281.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Yao, T. Taguchi, T. Matsumura, R. Pestell, D. Edelstein, I. Giardino, G. Suske, N. Rabbani, P. J. Thornalley, V. P. Sarthy, et al.
High Glucose Increases Angiopoietin-2 Transcription in Microvascular Endothelial Cells through Methylglyoxal Modification of mSin3A
J. Biol. Chem., October 19, 2007; 282(42): 31038 - 31045.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
V. Swarup, J. Ghosh, S. Ghosh, A. Saxena, and A. Basu
Antiviral and Anti-Inflammatory Effects of Rosmarinic Acid in an Experimental Murine Model of Japanese Encephalitis
Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3367 - 3370.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. A. Vincent and S. Mohr
Inhibition of Caspase-1/Interleukin-1{beta} Signaling Prevents Degeneration of Retinal Capillaries in Diabetes and Galactosemia
Diabetes, January 1, 2007; 56(1): 224 - 230.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Z. Arvanitakis, J. A. Schneider, R. S. Wilson, Y. Li, S. E. Arnold, Z. Wang, and D. A. Bennett
Diabetes is related to cerebral infarction but not to AD pathology in older persons
Neurology, December 12, 2006; 67(11): 1960 - 1965.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. E. Fox, X. Han, S. Kelly, A. H. Merrill Jr., R. E. Martin, R. E. Anderson, T. W. Gardner, and M. Kester
Diabetes Alters Sphingolipid Metabolism in the Retina: A Potential Mechanism of Cell Death in Diabetic Retinopathy
Diabetes, December 1, 2006; 55(12): 3573 - 3580.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. A. Antonetti, A. J. Barber, S. K. Bronson, W. M. Freeman, T. W. Gardner, L. S. Jefferson, M. Kester, S. R. Kimball, J. K. Krady, K. F. LaNoue, et al.
Diabetic Retinopathy: Seeing Beyond Glucose-Induced Microvascular Disease
Diabetes, September 1, 2006; 55(9): 2401 - 2411.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Saraswathy, G. Wu, and N. A. Rao
Retinal microglial activation and chemotaxis by docosahexaenoic Acid hydroperoxide.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3656 - 3663.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. J. Gastinger, R. S. J. Singh, and A. J. Barber
Loss of Cholinergic and Dopaminergic Amacrine Cells in Streptozotocin-Diabetic Rat and Ins2Akita-Diabetic Mouse Retinas.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3143 - 3150.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. S. Ola, D. A. Berkich, Y. Xu, M. T. King, T. W. Gardner, I. Simpson, and K. F. LaNoue
Analysis of glucose metabolism in diabetic rat retinas
Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1057 - E1067.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. Liu, H. S. Bal, T. Desta, Y. Behl, and D. T. Graves
Tumor Necrosis Factor-{alpha} Mediates Diabetes-Enhanced Apoptosis of Matrix-Producing Cells and Impairs Diabetic Healing
Am. J. Pathol., March 1, 2006; 168(3): 757 - 764.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.